e-learning
resources
Berlin 2001
Monday 24.09.2001
COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Changes in patients perception of dyspnoea, sputum volume and sputum purulence during treatment of chronic bronchitis exacerbations
Z. Z. Pavlovic-Popovic, Z. Zoricic-Major, M. Krivokapic, V. Pupavac, Z. Markovic (Sremska Kamenica, Yugoslavia)
Source:
Annual Congress 2001 - COPD
Session:
COPD
Session type:
Thematic Poster Session
Number:
1490
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Z. Z. Pavlovic-Popovic, Z. Zoricic-Major, M. Krivokapic, V. Pupavac, Z. Markovic (Sremska Kamenica, Yugoslavia). Changes in patients perception of dyspnoea, sputum volume and sputum purulence during treatment of chronic bronchitis exacerbations. Eur Respir J 2001; 16: Suppl. 31, 1490
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Sputum eosinophilia in patients with chronic cough
Source: Eur Respir J 2007; 30: Suppl. 51, 585s
Year: 2007
frequent exacerbations of COPD are associated with severity of airflow limitation and chronic cough, sputum production.
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019
Induced sputum concentrations of mucin in patients with asthma and chronic cough
Source: Eur Respir J 2007; 30: Suppl. 51, 61s
Year: 2007
Significance of sputum purulence to guide antibiotic therapy in exacerbations of COPD
Source: Eur Respir J 2013; 41: 248-249
Year: 2013
Significance of sputum purulence to guide antibiotic therapy in exacerbations of COPD
Source: Eur Respir J 2013; 41: 248
Year: 2013
Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD
Source: Eur Respir J 2012; 40: 1344-1353
Year: 2012
Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis
Source: Eur Respir J 2012; 39: 1354-1360
Year: 2012
Effect of sputum bacteriology on the prognosis of patients with acute exacerbations of bronchiectasis
Source: International Congress 2017 – COPD and weaning
Year: 2017
Predictors of sputum eosinophilia in severe asthma
Source: Virtual Congress 2020 – Clinical parameters in severe asthma
Year: 2020
Definition and aetiology of infective exacerbations of COPD
Source: Eur Respir Monogr 2013; 60: 58-67
Year: 2013
Persistent sputum eosinophilia in patients with difficult-to-treat asthma
Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up
Year: 2010
Factors associated with sputum purulence in stable moderate to severe COPD patients
Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Year: 2007
Sputum bacteriology in acute COPD exacerbations: correlation with FEV
1
deterioration
Source: Eur Respir J 2001; 18: Suppl. 33, 189s
Year: 2001
Breathlessness and its relationship to changes in spirometry during exacerbations of chronic bronchitis
Source: Eur Respir J 2002; 20: Suppl. 38, 254s
Year: 2002
Sputum purulence guided antibiotic therapy in patients with exacerbations of COPD requiring hospitalization
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008
Inflammatory markers in sputum of patients with cough variant asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 584s
Year: 2002
Inflammatory subtypes in cough variant asthma (CVA): assessment using induced sputum
Source: Annual Congress 2007 - Asthma subphenotypes
Year: 2007
The relation of sputum color to bacterial load in exacerbations of COPD
Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD
Year: 2008
Influence of age, gender and respiratory function inpairment on acceptability for culture of sputum samples in microbiological study during acute exacerbation of chronic bronchitis
Source: Eur Respir J 2003; 22: Suppl. 45, 217s
Year: 2003
The relation between pathogenic bacteriology in sputum and lung function in patients with acute exacerbation of COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 592s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept